Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 16, 2023

Total Value ($000): $329 (100.0% shares, 0.0% debt)

Holdings (12)

BIIB BIOGEN INC 15.0%
Value ($000) $49 Shares 177,126 Est. Cost $267.94 Unrealized +3.3%
REGN REGENERON PHARMACEUTICALS 14.8%
Value ($000) $49 Shares 59,488 Est. Cost $342.96 Unrealized +118.7%
UTHR UNITED THERAPEUTICS CORP 13.7%
Value ($000) $45 Shares 202,110 Est. Cost $127.97 Unrealized +92.6%
EXEL EXELIXIS INC 12.6%
Value ($000) $41 Shares 2,135,868 Est. Cost $18.49 Unrealized -5.8%
ALKS ALKERMES PLC 11.9%
Value ($000) $39 Shares 1,395,797 Est. Cost $18.73 Unrealized +45.4%
EMBC EMBECTA CORP 9.1%
Value ($000) $30 Shares 1,062,123 Est. Cost $25.42 Unrealized -0.3%
CAH CARDINAL HEALTH INC 8.1%
Value ($000) $27 Shares 353,278 Est. Cost $56.53 Unrealized +26.5%
ENTA ENANTA PHARMACEUTICALS INC 7.4%
Value ($000) $24 Shares 603,301 Est. Cost $45.86 Unrealized +4.1%
— TARO PHARMACEUTICAL INDUS 4.7%
Value ($000) $16 Shares 641,910 Est. Cost $67.97 Unrealized —
EGRX EAGLE PHARMACEUTICALS INC 1.0%
Value ($000) $3 Shares 113,737 Est. Cost $44.36 Unrealized -33.1%
KOD KODIAK SCIENCES INC 0.9%
Value ($000) $3 Shares 459,489 Est. Cost $33.04 Unrealized -78.8%
VNDA VANDA PHARMACEUTICALS INC 0.7%
Value ($000) $2 Shares 361,560 Est. Cost $10.33 Unrealized -31.9%